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ABSTRACT
Cerebral revascularization continues to evolve as an option in the setting
of ischemia. The potential to favorably influence stroke risk and the natural history
of cerebrovascular occlusive disease is being evaluated by the ongoing Carotid
Occlusion Surgery Study and the Japanese Extracranial-Intracranial Bypass Trial.
For those patients who undergo bypass in the setting of ischemia, four key areas of
follow-up include functional neurological status, neurocognitive status, bypass
patency, and status of cerebral blood flow and perfusion. Several stroke scales that
can be used to assess functional status include the National Institutes of Health
Stroke Scale, Bathel Index, Modified Rankin Scale, and Stroke Specific Quality of
Life. Neurocognition can be checked using the Repeatable Battery for the
Assessment of Neuropsychological Status, among other tests. Bypass patency is
checked intraoperatively using various flow probes and postoperatively using
magnetic resonance angiography (MRA) or computed tomographic angiography
(CTA). Cerebral blood flow and perfusion can be assessed using a host of
modalities that include positron emission tomography (PET), xenon CT, single
photon emission computed tomography (SPECT), transcranial Doppler (TCD),
CT, andMR. Paired blood flow studies after a cerebral vasodilatory stimulus using
one of these modalities can determine the state of autoregulatory vasodilation
(Stage 1 hemodynamic compromise). However, only PET with oxygen extraction
fraction measurements can reliably assess for Stage 2 compromise (misery
perfusion). This article discusses the various clinical, neuropsychological, and
radiographic techniques available to assess a patient’s clinical state and cerebral
blood flow before and after cerebral revascularization.
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Cerebral revascularization continues to
evolve as an option in the setting of cerebral
ischemia. The primary indications for revasculari-
zation include patients with moyamoya syndrome
and those with carotid occlusion and are addressed
in other works. Although the Extracranial-
Intracranial (EC-IC) Bypass Study published in
1985 demonstrated failure of bypass to significantly
improve stroke risk over medical management, this
study preceded effective cerebral blood flow (CBF)
studies.1 Currently, the potential use of superficial
temporal artery to middle cerebral artery (STA-
MCA) bypass for ischemia in the setting of carotid
occlusion is being rigorously re-evaluated by the
Carotid Occlusion Surgery Study (COSS) funded
by the National Institutes of Health (NIH), which
further stratifies patients as candidates for surgery if
and only if they manifest with increased oxygen
extraction fraction (OEF) on positron emission
tomography (PET) scanning.2 The Japanese EC-
IC Bypass Trial (JET) is also rigorously evaluating
bypass to treat cerebrovascular occlusive disease.3
Other potential patients for revascularization, using
either surgical or endovascular techniques, include
those with severe, symptomatic MCA stenosis.4–9
However, these patients should be considered very
carefully because this group did worse after STA-
MCA bypass in the EC-IC Bypass Study and
because endovascular therapy carries a relatively
high complication rate.1,4–9
For those patients who do undergo bypass in
the setting of ischemia, four areas of follow-up
include: (1) long-term clinical follow-up for evi-
dence of symptomatic ischemia; (2) neuropsycho-
logical testing; (3) bypass patency; and (4) changes
in CBF. This article reviews potential follow-up for
these patients. As outcome measures play a larger
role in clinical follow-up and in reimbursement
schedules, it is incumbent on the clinician to
document as completely as possible the results of
revascularization. More important, rigorous follow-
up assists patients with their own prognosis and
progress.
NEUROLOGICAL FOLLOW-UP
In the past, an efficient neurological exam to include
basic motor function and orientation would encom-
pass the extent of review of a bypass patient.
However, current literature suggests a more critical
review of outcome measures to include functional
and cognitive status (and the association between
the two) is needed to adequately assess the clinical
benefit of cerebral revascularization.
Functional status can be assessed by any
number of stroke scales, with the most common
being the NIH Stroke Scale (NIH-SS), the Modi-
fied Rankin Scale (MRS), the Barthel Index (BI),
and the Stroke Specific Quality of Life Scale (SS-
QOL). The NIH-SS allows one to quantify the
clinical exam and is the industry standard in pre-
dicting poor outcomes after acute stroke.10 It can be
administered at baseline, 2 hours post treatment,
24 hours post onset of symptoms, at 7 to 10 days,
3 months, and further out as needed. Both the
MRS11 and the BI12 are commonly used scales
that measure disability or dependence in activities
of daily living in stroke patients. TheMRS is widely
used to assess global outcomes after stroke, while
the BI records indicators of independence in terms
of the disability caused by impairments. The SS-
QOL Scale is a relatively new scale specific to stroke
patients and is more comprehensive in attempting
to capture higher levels of physical function and
quality of life.13
While it is important to assess the functional
status of bypass patients, it is becoming clear that
this should be done in the context of assessing their
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cognitive status, which is discussed in detail
below The association between cognitive status
and functional outcomes in the setting of cerebral
revascularization is unknown at this time and
should be evaluated as secondary outcomes in future
studies.
NEUROCOGNITIVE FOLLOW-UP
A body of literature exists evaluating neurocognitive
improvement after cerebral revascularization. In
1977 Peerless and colleagues reported improvement
in the quality of life and reduction in the signs of
dementia in 50% of institutionalized patients who
received bypass surgery for cerebrovascular disease,
but they did not confirm with testing.14 Dull et al
found significant neurobehavioral impairment in
cerebral revascularization candidates, suggesting
the importance of pre- and postop testing.15 In
their study, the length of the longest preoperative
symptom correlated with the degree of neuropsy-
chological impairment.15 Binder and associates
evaluated a small group of surgical and medically
treated revascularization patients in 1982 with pre-
and postoperative neurocognitive testing and found
that both groups improved over time, postulating
either spontaneous remission or a practice effect
interpretation.16 Baird and colleagues found no
clear correlation between the degree and pattern
of intracranial stenosis to the extent of behavioral
impairment in revascularization candidates, likely
due to poor assessment of collateral blood flow.17
Brown and coworkers, however, found some corre-
lation between cognitive function and reduction in
regional CBF in bypass candidates.18 Payk et al
demonstrated significant intellectual improvement
in 5 psychological batteries in a series of 34 patients
who underwent bypass for occlusive disease, though
this study lacked a control group.19 Nielsen and
associates assessed 33 symptomatic EC-IC bypass
patients with cognitive testing preop and three
months postop and compared these with results in
10 patients with normal cognition undergoing mi-
nor surgery.20 The 10 right hemisphere patients had
mild preop deficits and no significant postop
deficits, whereas the left hemisphere patients had
abnormal scores in 5 of 15 tests performed preop-
eratively but only 1 abnormal test finding
(visual retention) 3 months postop.20 This small
study demonstrated intellectual improvement after
bypass though patients in this study were not
randomized for medical management. Baird
and coworkers studied 95 cerebral revascularization
candidates and found a modest correlation be-
tween neurocognitive deficits and real-world
dysfunction.21
The EC-IC Bypass Study did not report
improvement in cognitive function as a secondary
outcome.1 The COSS, in addition to determining
whether stroke and death are reduced after bypass,
will also assess clinical outcome using Rankin Scale
Score, NIH-SS score, modified BI, and SS-QOL
Assessment.2 It will be interesting to see whether
bypass patients demonstrate significant intellectual
improvement over medically managed patients in
this randomized, controlled study.
Specialized neurocognitive testing is impor-
tant since this technique may demonstrate more
significant deficits, or, more commonly, more ex-
tensive improvement than is captured by the func-
tional status assessed by most stroke scales. Cardiac
surgeons have more recently used formal neuro-
cognitive testing to pick up subtle and marked
temporary or permanent cognitive decline after
cardiac bypass surgery.22–24 Neurocognitive deficits
became quite apparent after aneurysm surgery in
patients who were thought to have a normal neuro-
logical exam but in reality had some deficits when
assessed with the Mini-Mental State Examination
(MMSE) and MRS in the International Study
for Unruptured Intracranial Aneurysms (ISUIA).25
In contradistinction to aneursym surgery, patients
who undergo cerebral revascularization surgery
tend to have improvements in their neurocognitive
function, potentially another validation for the
surgery. The COSS may elucidate some of
the neurological improvements as a secondary
endpoint.2
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REPEATABLE BATTERY FOR
THE ASSESSMENT OF
NEUROPSYCHOLOGICAL STATUS
Neurocognitive testing for cerebral revasculariza-
tion patients would ideally capture all pre- and
postoperative deficits and would be easy to admin-
ister. Some of the tests noted above such as MRS,
the SS-QOL, and the BI, though well tested and
good for function, may miss some of the finer
neurocognitive deficits. The MMSE is currently
the most widely used screening instrument by
health-care providers and offers excellent sensitivity
for the rapid evaluation of cognitive status.26 How-
ever, it cannot specify particular areas of cognitive
impairment.27 The Repeatable Battery for the As-
sessment of Neuropsychological Status (RBANS)
was initially conceptualized as an instrument to be
used in the detection and characterization of de-
mentia in a geriatric population.28 Similar to the
Dementia Rating Scale (DRS) and the MMSE,
the RBANS provides a brief yet sensitive method
for assessing functioning across various cognitive
domains.26,28,29
The RBANS was developed to be used as a
stand-alone ‘‘core battery’’ for detecting and differ-
entiating dementia, and as a neuropsychological
‘‘screening battery’’ for use when lengthier batteries
are inappropriate.30 Specifically, the battery was
designed with the following parameters: (1) brevity
of administration; (2) difficulty level appropriate
for the normal older adult through those with
moderately severe dementia; (3) the ability to profile
impairment across cognitive domains for the pur-
pose of differential diagnosis and treatment plan-
ning; and (4) alternate forms to avoid practice
effects, track disease progression, and note improve-
ment in therapeutic interventions.28 The RBANS
therefore may lend itself to serial testing of cerebral
bypass patients.
The RBANS battery takes less than
30 minutes to administer and yields scaled scores
for the five cognitive domains of immediate mem-
ory, visuospatial/constructional, language, atten-
tion, and delayed memory.28 The brevity of the
instrument makes it ideal for administration to
older individuals and to individuals with compro-
mised health, both groups that are prone to fatigue
and less likely to endure the typical neuropsycho-
logical evaluation requiring 6 or more hours. Fur-
thermore, unlike the RBANS, the standard
neuropsychological battery lacks alternative forms
which limit its clinical utility in tracking disease
progression or recovery.
Research has examined the RBANS’ ability
to differentiate cortical dementias (i.e., Alzheimer’s
disease) from subcortical dementias (i.e., Hunting-
ton’s disease, Parkinson’s disease) and as a screening
tool in patients with schizophrenia.31,32 Randolph
et al compared the sensitivity of the RBANS to the
Dementia Rating Scale.28 The results indicated that
the RBANS had greater sensitivity and specificity
for identifying cognitive impairment in a demented
population. The RBANS also demonstrated clear
sensitivity to the type of impairment seen in indi-
viduals with schizophrenia.33
The RBANS appears to provide the sensitiv-
ity and reliability required for repeated assessments.
Additionally, it offers age-scaled norms and an
alternative form to avoid practice effects. Although
it may have some limitations, such as not providing
a measure of problem solving/executive functioning,
it appears to be a clinically useful screening instru-
ment with adequate test-retest stability.33 In sum-
mary, the RBANS may provide an additional
neurocognitive test to evaluate perioperative cere-
bral bypass patients due to these attributes: rapidity
of use, the ability to profile deficits across cognitive
domains, age-scaled norms, and alternative forms to
avoid the practice effect of serial exams.
RADIOGRAPHIC ASSESSMENT
Radiographic imaging plays an important role in
assessing both the technical and functional success
of EC-IC bypass for revascularization in the setting
of cerebral ischemia. Although outcome measures
relating to stroke reduction and neurocognitive and
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neurological outcome are the ultimate endpoints in
determining the efficacy of the intervention, imag-
ing can provide concrete markers for the technical
success of the procedure and for the anticipated
benefits in terms of flow augmentation.
BYPASS PATENCY
The technical success of EC-IC bypass can be
judged in the immediate, early, and delayed settings
by assessing the patency of the bypass. Different
modalities are useful based upon each of these time
frames.
Intraoperative Assessment
of Bypass Patency
Immediate appraisal of bypass patency following
vessel anastomosis is desirable intraoperatively to
identify inadequate or occluded grafts and to allow
the opportunity to revise a technically unsuccessful
anastomosis. Generally the immediate evaluation of
patency is performed first by visual inspection or
palpation of a pulse in the donor vessel; however,
these techniques can be notoriously inaccurate and
more objective measures are therefore routinely
advisable.
In recent years, intraoperative digital subtrac-
tion angiography has become a commonly used and
routine method for assessing cerebrovascular inter-
ventions during surgery.34–37 Angiographic images
are considered the standard for visualizing anatomic
patency. However, there are constraints inherent
to performing angiography in the operating room
environment, including the need for a specified
intraoperative angiography team and equipment,
and the increased technical difficulty of performing
selective vessel catheterization imposed by operative
patient positioning. Intraoperative angiography also
prolongs surgery and adds exposure to an additional
invasive procedure and ionizing radiation. Another
emerging option for verification of immediate graft
patency, which avoids the disadvantages of standard
angiography, is that of indocyanine green (ICG)
angiography.38,39 This technique involves intrave-
nous administration of ICG dye, which is then
visualized by illuminating the operating field with
infrared excitation light; the intravascular fluores-
cence of the dye can be visualized to demonstrate
flow through the bypass (Fig. 1). This technique
allows a simple method for documenting bypass
patency.
Beyond anatomic visualization, techniques
for assessing the flow dynamics of the bypass intra-
operatively can provide additional valuable infor-
mation. Microvascular Doppler is a simple real-
time method for assessing the presence of flow in
a bypass during surgery,40 but its output is primarily
qualitative and may not reliably distinguish between
poor and robust flow. Quantitative assessment of
patency can be reliably and repeatedly performed
with direct measurements of flow using an ultra-
sonic perivascular flow probe device (Charbel
Micro-flowprobe, Transonics Inc.).41–43 Such in-
formation regarding the flow rate through a bypass
can be a particularly useful adjunct in assessing
bypass function. For in situ vessel bypass such as
STA-MCA or occipital artery-posterior inferior
cerebellar artery bypass, which is most commonly
used for revascularization in the setting of ischemia,
quantitative flow measurements not only assess
Figure 1 ICG angiography of bypass. ICG, indocyanine
green.
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intraoperative patency but can also predict the
risk of future bypass failure.41 The ratio of flow in
cc/min through the bypass (bypass flow) to the flow
through the cut free end of the donor vessel prior to
bypass (cut flow) provides an index termed the cut
flow index (CFI). The CFI provides a sensitive
predictor of postoperative bypass patency. In a study
of 51 bypass procedures for flow augmentation in
the setting of ischemia, a CFI below 0.5 (indicating
bypass flow rates less than 50% of initial cut flow)
was associated with a patency rate of 50%, compared
with 92% in cases with CFI greater than 0.5.41
Reasons for a poor CFI included problems with the
donor vessel (iatrogenic injury, atheromatous
vessel), anastomosis (clot formation at suture line),
or recipient vessel (inadequate recipient vessel or
diffusely diseased vascular bed); identification of
such problems can allow decision-making intra-
operatively to rectify the problem and improve
ultimate bypass success. Given that bypasses with
a low CFI are often patent at the time of surgery,
such results also highlight the notion that mere
anatomic patency intraoperatively may not be as
useful in predicting a successful bypass procedure as
the assessment of intraoperative bypass flow.
Postoperative Assessment
of Bypass Patency
Patency in the early postoperative period or for
longer-term delayed follow-up has traditionally
been performed with angiography.1,44–46 Grading
systems to define the relative success of the bypass
have been applied, attempting to classify the success
of bypass function based upon the extent of the
vascular tree filled by the graft.1,47 However, such
anatomic grading systems have not been shown to
correlate well with outcome.1
For routine follow-up a less invasive modality
than angiography is desirable. Clinical exam alone
has been advocated as an adequate method for such
follow-up. In a series of 415 STA-MCA bypasses
for carotid occlusive disease, Sundt and colleagues
reported 98% correlation between the findings on
physical examination (digital palpation of the donor
vessel pedicle) and angiography in the first 260 cases
who were studied with both.48 The high angio-
graphic patency (99%) makes the correlation less
meaningful, because few occlusions were present to
assess the specificity of the clinical exam. In cases
where the branch of the STA not utilized for bypass
is left open, a pulse in the STA pedicle could reflect
flow through the patent native branch and erro-
neously suggest patency of the graft itself. In the
remainder of their 415 patients, Sundt and asso-
ciates advocated the use of physical examination and
Doppler ultrasonography, abandoning routine an-
giography.
In the current era, new imaging modalities
allow further options for noninvasive visualization
of bypass patency. Both computed tomographic
angiography (CTA) and magnetic resonance an-
giography (MRA) can be readily used to assess
grafts postoperatively49–53 and for serial follow-up.
CTA with 3-D reconstructions can provide exqui-
site details of the anatomy of the bypass (Fig. 2),
serving as a convenient replacement for catheter
angiography. Comparison of CTA and catheter
angiography in small groups of patients following
bypass have shown excellent correlation.52,53 Fur-
thermore, whereas angiography may require multi-
ple views to profile the anastomosis, which could
mean prolonged catheterization and multiple con-
trast injections, once a CTA scan is performed, an
infinite number of projections can be recreated from
the images. Changes in the function of the bypass
may potentially be inferred from changes in the
caliber of the bypass, but more specific information
regarding bypass function is difficult to obtain from
the static images provided by both CTA and stand-
ard angiography. The rate of contrast dye filling and
washout during angiographic procedures may give
some indication of flow changes within a bypass, but
is difficult to quantify and compare between studies.
New MRA techniques, on the other hand, now
provide the ability to quantify flow rates through
cerebral vessels, adding a new dimension to the
radiographic assessment of bypass grafts. The tech-
nique of quantitative MRA provides the ability
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to measure flow in cc/min directly in vessels of
interest54–58 (Fig. 3). Therefore, blood flow in a
bypass can be measured and followed longitudinally
not merely on the basis of its structural appearance,
but on the basis of its flow,59 providing a method for
assessing long-term patency and function. There are
few studies addressing long-term efficacy of bypass
function, but Schick et al have reported that bypass
function can worsen over time, with failure occur-
ring at an average of 2.7 years for STA-MCA grafts
and 1.4 years for vein grafts in patients treated for
ICA occlusion.60 Serial follow-up is therefore an
Figure 2 CTA demonstrating right STA-MCA bypass. (A) Lateral view with surface rendering demonstrating entry of the
STA pedicle (arrows) through the craniotomy site. (B) PA view demonstrating the anastamosis (arrow). CTA, computed
tomographic angiography; STA-MCA, superficial temporal artery-middle cerebral artery; PA, posterior-anterior. (Courtesy
of P. Roc Chen, M.D.)
Figure 3 Right STA-MCA bypass for ischemic symptoms in the setting of right M1 vessel occlusion. (A) Angiogram and
(B) 3-D MRA rendition used to define the bypass for quantitative flow measurement are shown. The arrow indicates the
anastamosis. The flow in this robust STA bypass was 87mL/min. STA-MCA, superficial temporal artery-middle cerebral
artery; MRA, magnetic resonance angiography.
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important aspect of judging the long-term success
of the bypass.
CBF AND PERFUSION
There are a multitude of imaging modalities aimed
at assessing adequacy of cerebral perfusion before
and after cerebral revascularization surgery. These
include PET, xenon CT, single positron emission
computed tomography (SPECT), transcranial
Doppler (TCD), CT, and MR modalities.61 Each
modality has its own relative advantages and
disadvantages. The goal of postoperative perfusion
assessment is to identify improvements that
can verify the success of the flow augmentation
procedure.
The premise for current methods of assessing
cerebral perfusion in the setting of cerebrovascular
occlusive disease has been to identify those patients
suffering from hemodynamic compromise as the
source of ischemic symptoms. Degrees of cerebral
hemodynamic impairment can be classified into two
basic categories designated as Stage 1 and Stage 2
hemodynamic compromise. Stage 1 compromise
refers to autoregulatory vasodilation, which occurs
to maintain normal CBF by reducing the vascular
resistance. As perfusion pressure decreases further,
the capacity for maintaining normal blood flow by
autoregulatory vasodilation is overcome, and CBF
decreases; the brain compensates by increasing the
extraction of oxygen from the blood to maintain
normal cerebral oxygen metabolism referred to as
Stage 2 compromise.
Stage 1 compromise can be inferred by quan-
tifying perfusion parameters such as CBF and
cerebral blood volume (CBV), with an increase in
CBV or CBV/CBF ratio reflecting autoregulatory
vasodilation. Such quantitative measurements can
only be made reliably with PET, as is also the case
with the assessment of increased OEF, which
defines Stage 2 compromise (misery perfusion).
Parameters indicating misery perfusion have been
correlated with increased stroke incidence after
carotid occlusion.62 PET therefore has emerged as
the gold standard predictive and quantitative tool
for assessing critical hypoperfusion. Small studies
have supported improvement in PET-measured
misery perfusion following bypass,63,64 and this
imaging modality is being used to select patients
for the ongoing U.S. randomized clinical COSS
trial to assess the efficacy of bypass in carotid
occlusion.2 However, PET is not a universally
available imaging modality.
Identification of the presence and degree of
autoregulatory vasodilation (Stage 1) can also be
assessed with the use of paired blood flow measure-
ments, with the initial measurement obtained at
baseline and the second following a vasodilatory
stimulus such as acetozolamide or hypercapnea or
physiologic tasks such as hand movement. The
response to the vasodilatory stimulus reflects cere-
brovascular reserve capacity and can be graded as
reduced, absent, or a paradoxical reduction com-
pared with baseline, referred to as steal phenom-
enon. Paired measurements can be obtained using
a variety of modalities: SPECT, xenon CT, TCD,
PET, MR, and CT perfusion,61 and correlations
with stroke risk have been described.65–69 Xenon
CT is a quantitative perfusion assessment tool,
with validation studies which have shown that it is
a reliable method of assessing cerebral perfusion70
but it is no longer widely available; other disadvan-
tages include long acquisition time (and resultant
difficulty with motion artifact) and occasional re-
actions of nausea or dizziness. SPECT imaging,
which utilizes the radionuclide 99mTc-HMPAO,
has been extensively used, but is primarily a qual-
itative tool subject to reader variability. It is
also limited by availability and cost. A less costly
method of assessment is the use of TCD with
either Diamox or breath-holding challenge to
assess for reserve.66,69 CT perfusion, using standard
spiral CT scanner and an intravenous bolus injec-
tion of iodinated contrast, has the advantage of
wide availability and holds the potential to provide
quantitative data,71,72 although not currently estab-
lished to do so. MR perfusion studies as well as
the technique of functional imaging looking for
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changes in the blood oxygen level dependent
(BOLD) signal with physiologic tasks73,74 are
promising modalities, but are also qualitative and
not as yet well validated. The qualitative tools are
useful to assess unilateral disease, but are generally
inadequate in patients with bilateral or global path-
ology. There have been no studies to compare
the relative accuracy of each of these modalities,
although the challenge tests are all based on a
similar premise of identifying loss of cerebrovascular
reserve. The relative sensitivity and specificity of
the tests may vary in this regard, and therefore it
is important to use the same modality for comparing
pre- and postoperative testing in a particular
individual.
Several studies have also incorporated these
paired blood flow measurements into the postoper-
ative evaluation of patients following revasculariza-
tion with bypass. Whereas some have reported
improvement in hemodynamic parameters follow-
ing bypass,47,75–79 others found improvement only
in a subset of patients,80–82 or early improvement
which was not long-lasting.83–85 Improvements
may be most prominent in patients with the greatest
degree of compromise preoperatively and are
more often seen in cerebrovascular reserve rather
than resting CBF.47,79,80 Nonetheless, changes in
the postoperative setting are difficult to interpret
definitively without comparison to similar non-
operated patients, given that even spontaneous
improvement in hemodynamic parameters have
been described,86,87 presumably due to collateral
formation.
Perfusion assessment even with the spectrum
of modalities described has primarily shown its
utility in the anterior circulation. Resolution for
detecting critical posterior circulation hypoperfu-
sion is limited.88 An alternative tool to assess the
adequacy of collateral circulation from a blood-flow
standpoint entails quantitative MR flow measure-
ment in the vertebrobasilar tree. The effect of
occlusive vertebrobasilar disease upon distal terri-
tory can be surmised from flow in the basilar trunk
and posterior cerebral arteries—if these flows are
compromised based on flow measurements com-
pared with normative baselines, hemodynamic com-
promise can be inferred.89 Follow-up of patients
with reduced distal flow with such an algorithm has
demonstrated higher stroke rates compared with the
benign course in those without distal flow compro-
mise.89 Remeasurement of flows following inter-
vention such as bypass could potentially assess the
success of re-establishing adequate distal flow.
Ultimately, the success of the revasculariza-
tion procedure is judged by its ability to favorably
influence the natural history and stroke risk of
the underlying cerebrovascular occlusive disease,
an issue that is currently being addresses by the
ongoing COSS2 and JET3 studies in the U.S. and
Japan. However, measures of blood flow and perfu-
sion provide an adjunctive indication of bypass
success. Establishing improvement in perfusion
postoperatively is an important step in verifying
that the bypass has adequately performed the goal
of augmenting flow.
CONCLUSIONS
Cerebral revascularization in the setting of ischemia
has had a resurgence of interest, spearheaded by the
COSS and JET studies. The evolution of medicine
has mandated that we are able to articulate out-
comes from invasive procedures such as EC-IC
bypass for ischemia. The various stroke scales such
as the NIH-SS, MRS, the BI, and the SS-QOL
scale provide an excellent assessment of functional
status. More refined assessment of neurocognitive
function may be achieved using the RBANS,
among others.
Assessment of bypass patency intraopera-
tively can maximize the potential success of the
procedure and may be accomplished with the qual-
itative microvascular Doppler probe or the quanti-
tative Charbel Micro-flowprobe. An emerging
option for verification of immediate graft patency
is that of ICG angiography dye. Delayed patency
can be followed with CTA or MRA, avoiding the
morbidity and expense of catheter angiography.
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The adequacy of cerebral perfusion can be
assessed before and after cerebral revascularization
surgery using one or more of a multitude of modal-
ities that include PET, xenon CT, SPECT,
TCD, CT, and MR. Identification of the pres-
ence and degree of autoregulatory vasodilation
(Stage 1) can be assessed with the use of paired
blood flow measurements, with the initial measure-
ment obtained at baseline and the second following
a vasodilatory stimulus. Paired measurements can
also be obtained using a variety of modalities:
SPECT, xenon CT, TCD, PET, MR, and CT
perfusion. However, quantitative measurements can
only be made reliably with PET, measuring in-
creased OEF which defines Stage 2 compromise
(misery perfusion). The goal of postoperative per-
fusion assessment is to identify improvements that
can verify the success of the flow augmentation
procedure.
DISCLAIMER
The views expressed in this article are those of the
authors, and do not reflect the official policy or
position of the Department of the Navy, Depart-
ment of Defense, or the United States Government.
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